Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for F/m Investments Life Sciences ETF (LFSC:NASDAQ), powered by AI.
F/m Investments Life Sciences ETF is currently trading at $40.17. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for F/m Investments Life Sciences ETF on Alpha Lenz.
View F/m Investments Life Sciences ETF's valuation metrics on Alpha Lenz.
F/m Investments Life Sciences ETF is an exchange-traded fund specifically tailored to capture the performance of companies operating within the life sciences sector. Its primary aim is to provide investors with exposure to a diversified basket of stocks that play a key role in life sciences innovation, including biotechnology, pharmaceuticals, and medical devices. This ETF is designed to track a benchmark index comprising firms that are at the forefront of developing cutting-edge medical technologies and healthcare solutions. Notable features of this ETF include its focus on both established and emerging companies, which allows it to capitalize on growth and resilience in the healthcare sector. The life sciences sector is critical in addressing global health challenges, making this ETF a significant vehicle for investors looking to participate in healthcare advancements. As part of the broader financial market, the F/m Investments Life Sciences ETF serves as a versatile instrument for institutional and retail investors aiming to diversify their portfolios with a focused tilt towards healthcare innovation.
F/m Investments Life Sciences ETF (ticker: LFSC) is a company listed on NASDAQ in the Unknown sector (Unknown).
The current price is $40.166 with a P/E ratio of -x and P/B of -x.